Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP).

Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon pumping across ...

According to InvestingPro analysis, the company maintains a strong financial ... potential gains in the intra-aortic balloon pump (IABP) market, and a solid balance sheet. Teleflex's recent ...

The AC3 Range IABP will enter full market release in the United States and will begin shipping to customers in the second quarter of 2025. The company said its AC3 Range IABP combines the simple ...

Leveraging the patented technology of the AC3 Optimus™ IABP, the AC3 Range™ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...

The AC3 Range IABP combines the simple interface and proprietary algorithms ... which may cause actual results or company actions to differ materially from what is expressed or implied by these ...